BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 20660883)

  • 21. Skin reactions to co-trimoxazole.
    Schöpf E
    Infection; 1987; 15 Suppl 5():S254-8. PubMed ID: 2963792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxic epidermal necrolysis following combination of methotrexate and trimethoprim-sulfamethoxazole.
    Yang CH; Yang LJ; Jaing TH; Chan HL
    Int J Dermatol; 2000 Aug; 39(8):621-3. PubMed ID: 10971734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Wildermuth A
    JAAPA; 2020 Aug; 33(8):48-49. PubMed ID: 32740115
    [No Abstract]   [Full Text] [Related]  

  • 24. Toxic epidermal necrolysis due to cotrimoxazole.
    Lipozencic J; Milavec-Puretic V; Kotrulja L; Tomicic H; Stulhofer Buzina D
    J Eur Acad Dermatol Venereol; 2002 Mar; 16(2):182-3. PubMed ID: 12046835
    [No Abstract]   [Full Text] [Related]  

  • 25. A slow acetylator genotype is a risk factor for sulphonamide-induced toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Wolkenstein P; Carrière V; Charue D; Bastuji-Garin S; Revuz J; Roujeau JC; Beaune P; Bagot M
    Pharmacogenetics; 1995 Aug; 5(4):255-8. PubMed ID: 8528274
    [No Abstract]   [Full Text] [Related]  

  • 26. Toxic epidermal necrolysis. A widespread, life-threatening blistering reaction.
    Watanakunakorn P; Brodell RT
    Postgrad Med; 2000 Apr; 107(4):29-30. PubMed ID: 10778408
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of macrophage migration inhibition factor in toxic epidermal necrolysis.
    Halevy S; Livni E
    Int J Dermatol; 1997 Oct; 36(10):776-8. PubMed ID: 9372356
    [No Abstract]   [Full Text] [Related]  

  • 28. Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry.
    Diphoorn J; Cazzaniga S; Gamba C; Schroeder J; Citterio A; Rivolta AL; Vighi GD; Naldi L;
    Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):196-203. PubMed ID: 26687641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Case of Drug-Induced Stevens-Johnson Syndrome.
    Lyon DR; Akinboboye O; Jain PV; Jha P
    WMJ; 2022 Oct; 121(3):E63-E65. PubMed ID: 36301663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trimethoprim/sulfamethoxazole desensitization in an HIV-positive patient with previous Stevens-Johnson syndrome; a failed study.
    Ansari R; Ghaderkhani S; Namazi S
    Daru; 2023 Jun; 31(1):69-73. PubMed ID: 37002421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Associated With Antibiotic Use: A Case-Crossover Study.
    Fukasawa T; Urushihara H; Takahashi H; Okura T; Kawakami K
    J Allergy Clin Immunol Pract; 2023 Nov; 11(11):3463-3472. PubMed ID: 37459954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Stevens-Johnson syndrome and toxic epidermal necrolysis following intake of sulfonamides].
    Aberer W; Stingl G; Wolff K
    Hautarzt; 1982 Sep; 33(9):484-90. PubMed ID: 7174320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cotrimoxazole Induced Steven Johnson Syndrome: A Case Report.
    Acharya A; Acharya SP; Bhattarai TR
    JNMA J Nepal Med Assoc; 2020 Sep; 58(229):702-704. PubMed ID: 33068096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Co-trimoxazole for toxic epidermal necrolysis in AIDS.
    Senneville E; Lecocq P; Ajana F; Chidiac C; Mouton Y
    Lancet; 1991 Apr; 337(8746):919. PubMed ID: 1672997
    [No Abstract]   [Full Text] [Related]  

  • 35. Fatal toxic epidermal necrolysis associated with co-trimoxazole.
    Carmichael AJ; Tan CY
    Lancet; 1989 Sep; 2(8666):808-9. PubMed ID: 2571053
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug-induced Lyell and Stevens-Johnson syndromes.
    Prescrire Int; 2009 Feb; 18(99):20-2. PubMed ID: 19391288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatal toxic epidermal necrolysis probably related to glimepiride in a patient with a medical history of hypersensitivity to sulfamethoxazole-trimethoprim.
    Ouni B; Fathallah N; Ben-Sayed N; Abdessayed N; Slim R; Sriha B; Ben Salem C
    Br J Clin Pharmacol; 2021 Mar; 87(3):1591-1593. PubMed ID: 32815205
    [No Abstract]   [Full Text] [Related]  

  • 38. Trimethoprim-sulfamethoxazole-induced linear IgA bullous disease presenting as toxic epidermal necrolysis.
    Baltazard T; Dhaille F; Duvert-Lehembre S; Lok C; Chaby G
    Dermatol Online J; 2017 Aug; 23(8):. PubMed ID: 29469749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cotrimoxazole induced dermatitis and curative treatment of AIDS pneumocystosis].
    Caumes E
    Rev Mal Respir; 1996; 13(2):101-6. PubMed ID: 8711227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cutaneous artifactual disease represented as recurrent toxic epidermal necrolysis.
    Gowring LE; Johnson R; Hivnor CM; Henning JS
    Cutis; 2016 Sep; 98(3):E6-E7. PubMed ID: 27814420
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.